Cypress Capital Management (Delaware)’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-64,103
| Closed | -$6.7M | – | 190 |
|
|
2022
Q3 | $6.7M | Sell |
64,103
-18,371
| -22% | -$1.92M | 1.24% | 26 |
|
|
2022
Q2 | $8.67M | Sell |
82,474
-280
| -0.3% | -$29.4K | 1.29% | 24 |
|
|
2022
Q1 | $10.6M | Sell |
82,754
-1,812
| -2% | -$232K | 1.33% | 24 |
|
|
2021
Q4 | $10.4M | Buy |
84,566
+11,575
| +16% | +$1.43M | 1.18% | 31 |
|
|
2021
Q3 | $11.4M | Hold |
72,991
| – | – | 1.51% | 22 |
|
|
2021
Q2 | $11.4M | Sell |
72,991
-113
| -0.2% | -$17.6K | 1.5% | 22 |
|
|
2021
Q1 | $11.4M | Sell |
73,104
-14,534
| -17% | -$2.26M | 1.56% | 18 |
|
|
2020
Q4 | $13.1M | Buy |
87,638
+227
| +0.3% | +$34K | 1.79% | 16 |
|
|
2020
Q3 | $11.6M | Sell |
87,411
-484
| -0.6% | -$64K | 1.77% | 16 |
|
|
2020
Q2 | $10.2M | Sell |
87,895
-546
| -0.6% | -$63.3K | 1.66% | 21 |
|
|
2020
Q1 | $8.68M | Buy |
88,441
+62
| +0.1% | +$6.08K | 1.71% | 21 |
|
|
2019
Q4 | $12.8M | Sell |
88,379
-72
| -0.1% | -$10.5K | 1.97% | 16 |
|
|
2019
Q3 | $11.8M | Buy |
88,451
+11,350
| +15% | +$1.51M | 1.93% | 18 |
|
|
2019
Q2 | $8.81M | Buy |
77,101
+6,757
| +10% | +$772K | 1.53% | 27 |
|
|
2019
Q1 | $8.72M | Buy |
70,344
+3,791
| +6% | +$470K | 1.61% | 28 |
|
|
2018
Q4 | $6.7M | Sell |
66,553
-12,402
| -16% | -$1.25M | 1.38% | 32 |
|
|
2018
Q3 | $10.1M | Buy |
78,955
+21
| +0% | +$2.68K | 1.76% | 25 |
|
|
2018
Q2 | $8.54M | Buy |
78,934
+8,204
| +12% | +$888K | 1.63% | 33 |
|
|
2018
Q1 | $7.49M | Buy |
+70,730
| New | +$7.49M | 1.45% | 38 |
|